Wholesale of pharmaceutical and medical goods
CIRCIUS PHARMA AS
Revenue 2024
NOK 13.0m
Operating profit
NOK −30,000
Equity
NOK 2.0m
Incorporated
2021
Share capital
NOK 300,000
Key figures · 2024
Current ratio
1.11
Equity ratio
26.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -0.2% | |
| Net margin (%%) | 0.0% | |
| Return on assets (%%) | -0.4% | |
| Likviditet | ||
| Current ratio | 1.11 | |
| Working capital | 590k | |
| Soliditet | ||
| Equity ratio (%%) | 26.8% | |
| Debt-to-equity ratio | 2.74 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.